International Patent: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING DELAYED GRAFT FUNCTION (DGF)

GENEVA, July 31 -- ALEXION PHARMACEUTICALS, INC. filed a patent application (US2026/012081) for “DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING DELAYED GRAFT FUNCTION (DGF)”. With publication no. WO/2026/161510, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....